Kineta Inc

NASDAQ:KA   3:59:50 PM EDT
-0.09 (-3.77%)
Twitter Share  Facebook Share StockTwits Share

Search For a Symbol

Market Cap (Intraday)22.47M
Current PEN/A
Forward PE N/A
2yr Forward PE N/A
See more stats
Estimates Current Quarter
Revenue$0.15 Million
Adjusted EPS-$0.56
See more estimates
10-Day MA$2.19
50-Day MA$2.11
200-Day MA$3.97
See more pivots

Kineta Inc Stock, NASDAQ:KA

219 Terry Avenue North, Suite 300, Seattle, Washington 98109
United States of America
Phone: +1.206.378.0400
Number of Employees: 11


Kineta, Inc. is a clinical-stage biotechnology company, which develops immunotherapies for cancer patients. Its immuno-oncology focused platform aims at developing fully human antibodies to address the major mechanisms of cancer immune resistance. The company was founded by Shawn P. Iadonato and Charles L. Magness in 2008 and is headquartered in Seattle, WA.